We provided evidence that these cytokines were more abundant in ALK + NSCLC patients compared to healthy controls, suggesting that IL-6, IL-8 and IL-10 could be relevant serum markers for NSCLC, as reported in other independent studies [6, 26, 27]. This evidence concerns the gene IL6 and non-small cell lung carcinoma.